Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8059.14x is 4635% below its 5-year average of -170.20x, near the high end of its 5-year range (-42335.00x–13.24x).
As of the fiscal period ended Thursday, September 30, 2021. 39.14% above its 12-month average of -13241.23x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2021 (2021-09-30): -8059.14x.
INTEREST COVERAGE RATIO
-8059.14x
INTEREST COVERAGE RATIO AVG TTM
-13241.23x
INTEREST COVERAGE RATIO AVG 3Y
-5444.85x
INTEREST COVERAGE RATIO AVG 5Y
-170.20x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+39.14%
CURRENT VS 3Y AVG
-48.01%
CURRENT VS 5Y AVG
-4635.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-126317.93%
vs the sector median at left
Cronos Group Inc.
Market Cap
$1.22B
Interest Coverage Ratio
-8059.14x
TTM Avg
-13241.23x
3Y Avg
-5444.85x
5Y Avg
-170.20x
Market Cap
$1.22B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.21B
Interest Coverage Ratio
15.57x
TTM Avg
15.57x
3Y Avg
15.57x
5Y Avg
10.02x
Market Cap
$1.20B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.19B
Interest Coverage Ratio
2.81x
TTM Avg
2.36x
3Y Avg
1.69x
5Y Avg
1.69x
Market Cap
$1.17B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
Interest Coverage Ratio
-4.99x
TTM Avg
16.08x
3Y Avg
16.08x
5Y Avg
16.08x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.22B | -8059.14x | -13241.23x | -5444.85x | -170.20x |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.22B | N/A | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.21B | 15.57x | 15.57x | 15.57x | 10.02x |
| Omada Health (OMDA)vs › | $1.23B | -4.72x | N/A | N/A | N/A |
| Kardigan, Inc. (KARD)vs › | $1.21B | N/A | N/A | N/A | N/A |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.20B | N/A | N/A | N/A | N/A |
| MannKind Corporation (MNKD)vs › | $1.19B | 2.81x | 2.36x | 1.69x | 1.69x |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.14B | -4.99x | 16.08x | 16.08x | 16.08x |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | -100.93x | N/A | N/A | N/A |
Interest Coverage
-8059.1x
Debt/Equity
0.00
Current Ratio
16.18
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-09-30 | -8059.14x |
| 2021-06-30 | -42335.00x |
| 2020-12-31 | -1947.00x |
| 2020-09-30 | -623.77x |
| 2020-06-30 | -1221.95x |
| 2019-12-31 | -147.99x |
| 2019-09-30 | -5.06x |
| 2019-06-30 | -6.37x |
| 2019-03-31 | -0.61x |
| 2018-09-30 | -101.63x |
| 2018-06-30 | 13.24x |
| 2018-03-31 | -99.03x |
| 2017-09-30 | -1.80x |
| 2017-03-31 | -4.73x |
| 2016-12-31 | 9.93x |
| 2016-09-30 | -22.76x |
| 2016-06-30 | -62.86x |
| 2016-03-31 | -10.26x |
| 2015-12-31 | 7.70x |
| 2015-09-30 | -22.53x |
| 2015-06-30 | -30.45x |
| 2015-03-31 | -98.16x |
